- DICAL REPORTS RECORD THIRD QUARTER 2019 REVENUES
- Third Quarter Revenues Increase 33% to $8.1 Million
- WatchPATTM Revenues Increase 32% in the Third Quarter to $7.6 Million
- Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT
CAESAREA, Israel, November 26, 2019 — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market, today reported unaudited financial results for the three months and ninemonth periods ended September 30, 2019.